- Home
- Publications
- Publication Search
- Publication Details
Title
Spontaneous regression of neuroblastoma
Authors
Keywords
Neuroblastoma, Regression, Spontaneous, TrkA, Telomerase
Journal
CELL AND TISSUE RESEARCH
Volume 372, Issue 2, Pages 277-286
Publisher
Springer Nature
Online
2018-01-05
DOI
10.1007/s00441-017-2761-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
- (2017) Alexander Drilon et al. Cancer Discovery
- Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model
- (2016) Radhika Iyer et al. CANCER LETTERS
- Infantile Fibrosarcoma WithNTRK3-ETV6Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101
- (2016) Ramamoorthy Nagasubramanian et al. PEDIATRIC BLOOD & CANCER
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
- (2015) R. C. Doebele et al. Cancer Discovery
- TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts
- (2014) Jamie L. Croucher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Mechanisms of neuroblastoma regression
- (2014) Garrett M. Brodeur et al. Nature Reviews Clinical Oncology
- EZH2 as a potential target in cancer therapy
- (2014) Michael T McCabe et al. Epigenomics
- Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma
- (2013) E. Barbieri et al. CANCER RESEARCH
- A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants
- (2012) Jed G. Nuchtern et al. ANNALS OF SURGERY
- DNA methylation inhibitors in cancer: Recent and future approaches
- (2012) Christina Gros et al. BIOCHIMIE
- AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts
- (2012) Radhika Iyer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant
- (2012) M. Samy et al. MOLECULAR CANCER THERAPEUTICS
- Neonatal neuroblastoma
- (2012) Jonathan P.H. Fisher et al. Seminars in Fetal & Neonatal Medicine
- Long-term Follow-up of the “Wait and See” Approach to Localized Perinatal Adrenal Neuroblastoma
- (2012) Denis Andrew Cozzi et al. WORLD JOURNAL OF SURGERY
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study
- (2011) Jane E. Minturn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The effect of P75 on Trk receptors in neuroblastomas
- (2011) Ruth Ho et al. CANCER LETTERS
- Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings
- (2011) Anneleen Decock et al. Epigenetics
- Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age
- (2011) Denah R. Taggart et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteomics-based identification of spontaneous regression-associated proteins in neuroblastoma
- (2011) Fang Yu et al. JOURNAL OF PEDIATRIC SURGERY
- Lestaurtinib Enhances the Antitumor Efficacy of Chemotherapy in Murine Xenograft Models of Neuroblastoma
- (2010) R. Iyer et al. CLINICAL CANCER RESEARCH
- Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients
- (2010) E. Grau et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not
- (2010) Vassiliki Nikoletopoulou et al. NATURE
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
- (2010) David L. Baker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dependence receptors: a new paradigm in cell signaling and cancer therapy
- (2010) D Goldschneider et al. ONCOGENE
- Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
- (2009) Cinzia Lavarino et al. BMC CANCER
- On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
- (2009) C. J. Thiele et al. CLINICAL CANCER RESEARCH
- Trk Receptor Expression and Inhibition in Neuroblastomas
- (2009) G. M. Brodeur et al. CLINICAL CANCER RESEARCH
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S
- (2008) Jean Bénard et al. Molecular Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started